Patients with refractory and difficult-to-treat Inflammatory Bowel Disease are underrepresented in randomized clinical trials

被引:0
|
作者
Parigi, T. L. [1 ,2 ,3 ]
Solitano, V [4 ,5 ]
Mekonnen, H. [5 ]
Yuan, Y. [5 ]
Jairath, V [5 ]
Danese, S. [3 ]
机构
[1] IRCCS San Raffaele Hosp, Dept Gastroenterol & Endoscopy, Milan, Italy
[2] Case Western Reserve Univ, Dept Pathol, Cleveland, OH USA
[3] Univ Vita Salute San Raffaele, Div Immunol Transplantat & Infect Dis, Milan, Italy
[4] Univ Vita Salute San Raffaele, Div Immunol Transplantat & Infect Dis, Milan, Italy
[5] Western Univ, Dept Med, Div Gastroenterol, London, ON, Canada
来源
关键词
D O I
10.1093/ecco-jcc/jjae190.1332
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P1158
引用
收藏
页码:I2114 / I2115
页数:2
相关论文
共 50 条
  • [21] INFLAMMATORY BOWEL DISEASE PATIENTS' PERSPECTIVES OF CLINICAL TRIALS
    Rubin, David T.
    Peyrin-Biroulet, Laurent
    Reinisch, Walter
    Tole, Swati
    Sullivan, Laura
    Park, Kun Tae
    Regueiro, Miguel D.
    GASTROENTEROLOGY, 2020, 158 (06) : S423 - S423
  • [22] INFLAMMATORY BOWEL DISEASE PATIENTS' PERSPECTIVES OF CLINICAL TRIALS
    Rubin, David
    Peyrin-Biroulet, Laurent
    Reinisch, Walter
    Tole, Swati
    Sullivan, Laura
    Park, K. T.
    Regueiro, Miguel
    GASTROENTEROLOGY, 2020, 158 (03) : S85 - S85
  • [23] INFLAMMATORY BOWEL DISEASE PATIENTS' PERSPECTIVES OF CLINICAL TRIALS
    Rubin, David
    Peyrin-Biroulet, Laurent
    Reinisch, Walter
    Tole, Swati
    Sullivan, Laura
    Park, K. T.
    Regueiro, Miguel
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S53 - S53
  • [24] Difficult-to-treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment
    Caron, Benedicte
    Habert, Alexandre
    Bonsack, Olivier
    Camara, Houda
    Jeanbert, Elodie
    Parigi, Tommaso Lorenzo
    Netter, Patrick
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024, 12 (05) : 605 - 613
  • [25] The clinical role of rTMS in difficult-to-treat depression
    Baune, B.
    EUROPEAN PSYCHIATRY, 2024, 67 : S14 - S14
  • [26] Racial and Ethnic Diversity in Inflammatory Bowel Disease Randomized Clinical Trials
    Pelton, Matt
    Ssentongo, Paddy
    Clarke, Kofi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S554 - S555
  • [27] The Clinical Implications of Aspergillus Fumigatus Sensitization in Difficult-To-Treat Asthma Patients
    Mistry, Heena
    Soberanis, Hilda Maria Ajsivinac
    Kyyaly, Mohammad Aref
    Azim, Adnan
    Barber, Clair
    Knight, Deborah
    Newell, Colin
    Haitchi, Hans Michael
    Wilkinson, Tom
    Howarth, Peter
    Seumois, Gregory
    Vijayanand, Pandurangan
    Arshad, S. Hasan
    Kurukulaaratchy, Ramesh J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12): : 4254 - +
  • [28] AIH: Which Alternative for Difficult-to-Treat Patients?
    Sebode, Marcial
    Schramm, Christoph
    DIGESTIVE DISEASES, 2015, 33 : 83 - 87
  • [29] Thoughtful prescribing for patients with difficult-to-treat depression
    Soubolsky, Amy
    Visentin, Jessica
    Crawley, Alex
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (11) : 777 - 783
  • [30] Treatment of hepatitis C in difficult-to-treat patients
    Peter Ferenci
    Nature Reviews Gastroenterology & Hepatology, 2015, 12 : 284 - 292